Hunting Hill Global Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hunting Hill Global Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,723	Closed	-$716K	–	103
2024 Q2	$716K	Sell	7,723 -16	-0.2%	-$1.44K	0.32%	49
2024 Q1	$734K	Sell	7,739 -4,582	-37%	-$425K	0.36%	58
2023 Q4	$1.1M	Sell	12,321 -11,804	-49%	-$877K	0.46%	44
2023 Q3	$1.76M	Buy	+24,125	New	+$1.93M	0.59%	32
2022 Q2	–	Sell	-11,000	Closed	-$826K	–	110
2022 Q1	$989K	Buy	+11,000	New	+$1.02M	0.81%	28

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Hunting Hill Global Capital's XBI Position: Q3 2024 in Review

Hunting Hill Global Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 7,723 shares — an estimated $716K sold.

Hunting Hill Global Capital first reported a position in XBI in Q1 2022 and held it in 5 quarters. The position peaked at $1.76M in Q3 2023. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Hunting Hill Global Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Hunting Hill Global Capital sold 7,723 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $716K.
Hunting Hill Global Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 5 quarters.
Hunting Hill Global Capital's State Street SPDR S&P Biotech ETF position peaked at $1.76M in Q3 2023.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Hunting Hill Global Capital's 13F filing for Q3 2024, filed 14 Nov 2024.